Gerresheimer AG (WBO:GXI) EV-to-EBIT : 20.11 (As of Apr. 26, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Gerresheimer AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Gerresheimer AG's Enterprise Value is €4,420 Mil. Gerresheimer AG's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was €220 Mil. Therefore, Gerresheimer AG's EV-to-EBIT for today is 20.11.

The historical rank and industry rank for Gerresheimer AG's EV-to-EBIT or its related term are showing as below:

WBO:GXI' s EV-to-EBIT Range Over the Past 10 Years
Min: 11.71 Med: 17.92 Max: 381.32
Current: 20.12

During the past 13 years, the highest EV-to-EBIT of Gerresheimer AG was 381.32. The lowest was 11.71. And the median was 17.92.

WBO:GXI's EV-to-EBIT is ranked worse than
50.86% of 464 companies
in the Medical Devices & Instruments industry
Industry Median: 19.675 vs WBO:GXI: 20.12

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Gerresheimer AG's Enterprise Value for the quarter that ended in Feb. 2024 was €4,776 Mil. Gerresheimer AG's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was €220 Mil. Gerresheimer AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was 4.60%.

Gerresheimer AG EV-to-EBIT Historical Data

The historical data trend for Gerresheimer AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG EV-to-EBIT Chart

Gerresheimer AG Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

EV-to-EBIT

Get a 7-Day Free Trial

24.71

25.85

24.02

19.71

18.04

Gerresheimer AG Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-EBIT	Get a 7-Day Free Trial															23.11	23.84	25.43	18.04	21.67

Competitive Comparison of Gerresheimer AG's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gerresheimer AG's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's EV-to-EBIT falls into.

Gerresheimer AG EV-to-EBIT Calculation

Gerresheimer AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	4419.992	/	219.744
	=	20.11

Gerresheimer AG's current Enterprise Value is €4,420 Mil.
Gerresheimer AG's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €220 Mil.

Gerresheimer AG (WBO:GXI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Gerresheimer AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Feb. 2024 )	=	EBIT	/	Enterprise Value (Q: Feb. 2024 )
	=	219.744	/	4776.154
	=	4.60 %

Gerresheimer AG's Enterprise Value for the quarter that ended in Feb. 2024 was €4,776 Mil.
Gerresheimer AG's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €220 Mil.

Gerresheimer AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Gerresheimer AG (WBO:GXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (WBO:GXI) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

GXId:UK 0NTI:UK GXI:Germany

Address

Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468

Website

https://www.gerresheimer.com

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Gerresheimer AG (WBO:GXI) Headlines

No Headlines